88 related articles for article (PubMed ID: 34186414)
1. The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.
Eklund C; Mühr LSA; Lagheden C; Forslund O; Robertsson KD; Dillner J
J Clin Virol; 2021 Aug; 141():104902. PubMed ID: 34186414
[TBL] [Abstract][Full Text] [Related]
2. Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study.
Arroyo Mühr LS; Eklund C; Lagheden C; Forslund O; Robertsson KD; Dillner J
J Clin Virol; 2022 Sep; 154():105237. PubMed ID: 35820294
[TBL] [Abstract][Full Text] [Related]
3. Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies.
Eklund C; Forslund O; Wallin KL; Dillner J
J Clin Virol; 2018 Apr; 101():74-85. PubMed ID: 29433017
[TBL] [Abstract][Full Text] [Related]
4. Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study.
Eklund C; Forslund O; Wallin KL; Dillner J
J Clin Microbiol; 2014 Feb; 52(2):449-59. PubMed ID: 24478473
[TBL] [Abstract][Full Text] [Related]
5. First international proficiency study on human papillomavirus testing in cervical cancer screening.
Yilmaz E; Eklund C; Lagheden C; Robertsson KD; Lilja M; Elfström M; Arroyo Mühr LS; Dillner J
J Clin Virol; 2023 Oct; 167():105581. PubMed ID: 37688950
[TBL] [Abstract][Full Text] [Related]
6. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology.
Eklund C; Forslund O; Wallin KL; Zhou T; Dillner J;
J Clin Microbiol; 2012 Jul; 50(7):2289-98. PubMed ID: 22535980
[TBL] [Abstract][Full Text] [Related]
7. Global proficiency study of human papillomavirus genotyping.
Eklund C; Zhou T; Dillner J;
J Clin Microbiol; 2010 Nov; 48(11):4147-55. PubMed ID: 20844222
[TBL] [Abstract][Full Text] [Related]
8. The International Human Papillomavirus Reference Center: Standardization, collaboration, and quality assurance in HPV research and diagnostics.
Arroyo Mühr LS; Lagheden C; Hassan SS; Eklund C; Dillner J
J Med Virol; 2023 Dec; 95(12):e29332. PubMed ID: 38115556
[TBL] [Abstract][Full Text] [Related]
9. Proficiency test for human papillomavirus genotyping in china.
Zhang R; Huang J; Wang P; Sun Y; Zhang K; Xie J; Gao S; Wang L; Li J
Intervirology; 2013; 56(5):295-301. PubMed ID: 23838312
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study.
Engesæter B; van Diermen Hidle B; Hansen M; Moltu P; Staby KM; Borchgrevink-Persen S; Vintermyr OK; Lönnberg S; Nygård M; Janssen EA; Castle PE; Christiansen IK
BMC Infect Dis; 2016 Nov; 16(1):698. PubMed ID: 27881082
[TBL] [Abstract][Full Text] [Related]
11. Towards quality and order in human papillomavirus research.
Mühr LSA; Eklund C; Dillner J
Virology; 2018 Jun; 519():74-76. PubMed ID: 29679790
[TBL] [Abstract][Full Text] [Related]
12. International standardization and classification of human papillomavirus types.
Bzhalava D; Eklund C; Dillner J
Virology; 2015 Feb; 476():341-344. PubMed ID: 25577151
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
[TBL] [Abstract][Full Text] [Related]
14. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
Cubie HA; Moore C; Waller M; Moss S;
J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
[TBL] [Abstract][Full Text] [Related]
15. Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Akbari A; Vanden Broeck D; Benoy I; Padalko E; Bogers J; Arbyn M
Virol J; 2018 Oct; 15(1):166. PubMed ID: 30373616
[TBL] [Abstract][Full Text] [Related]
16. Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks.
Godfrey CC; Michelow PM; Godard M; Sahasrabuddhe VV; Darden J; Firnhaber CS; Wetherall NT; Bremer J; Coombs RW; Wilkin T;
Am J Clin Pathol; 2013 Dec; 140(6):881-9. PubMed ID: 24225757
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid tests for the detection of alpha human papillomaviruses.
Poljak M; Cuzick J; Kocjan BJ; Iftner T; Dillner J; Arbyn M
Vaccine; 2012 Nov; 30 Suppl 5():F100-6. PubMed ID: 23199952
[TBL] [Abstract][Full Text] [Related]
18. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.
Frayle H; Gori S; Rizzi M; Graziani BN; Vian E; Giorgi Rossi P; Del Mistro A
BMC Womens Health; 2019 Mar; 19(1):47. PubMed ID: 30909894
[TBL] [Abstract][Full Text] [Related]
19. The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate.
Kono K; Morisada T; Saika K; Aoki ES; Miyagi E; Ito K; Takahashi H; Nakayama T; Saito H; Aoki D
J Gynecol Oncol; 2021 May; 32(3):e29. PubMed ID: 33559411
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus typing by single tube multiplex amplification in real time (SMART): the PapillomaFinder® SMART 20 assay.
Ossel J; Litjens RJ; Reijans M; Brink AA; Ummelen M; Ramaekers FC; Hopman AH; Simons G
J Clin Virol; 2014 Dec; 61(4):540-7. PubMed ID: 25453331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
